Navigation Links
Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Date:10/29/2012

SAN FRANCISCO, Oct. 29, 2012 /PRNewswire/ -- Principia Biopharma, Inc., a privately-held biopharmaceutical company focused on advancing best-in-class medicines in immunology, autoimmune diseases, and oncology announced that it successfully met its milestone obligations and received its second tranche of funding totaling $12.5 million in July 2012. The investment was led by existing investors New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.  In February 2011, Principia completed a tiered Series A round of financing totaling $36.3 million and received the first tranche of $12 million that same month.  Proceeds from this most recent financing will be used to advance Principia's lead molecule towards the clinic and to develop additional programs enabled by the company's reversible covalent platform.

(Logo: http://photos.prnewswire.com/prnh/20121029/NY01747LOGO)

Martin Babler, CEO of Principia, says, "We are pleased to complete the closing of our second tranche as it provides the necessary funding for Principia to advance our lead compound toward our first clinical trials in 2013. We appreciate the continued support from our current investors as we invest in important treatments for cancer and autoimmune disorders."

EXPANSION OF SENIOR MANAGEMENT TEAM

As part of Principia's growth and its initiatives to bring new medicines to patients, the company has expanded its senior management team with the hiring of Jens Oliver Funk, M.D. as Chief Scientific Officer (C
'/>"/>

SOURCE Principia Biopharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
2. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
3. PDL BioPharma Completes Regular Quarterly Dividend Payment
4. Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
5. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
6. PDL BioPharma to Present at Upcoming Investor Conferences
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
9. BioWorld Launches Enhanced Biopharma News Site with Data, Analysis
10. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
11. New Stroke Drug from ZZ Biotech Produced by Laureate Biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Zacks.com announces the list of stocks featured in ... discuss the latest news and events impacting stocks and the ... (NYSE: HPQ - Free Report ), IBM (NYSE: ... SB - Free Report ), GlaxoSmithKline plc (NYSE: GSK ... FI - Free Report ). Today, Zacks is ...
(Date:8/21/2014)... , Aug. 21, 2014  Armada Health Care ... organization (GPO), is pleased to announce an agreement ... a host of innovative specialty pharmacy patient program ... enhanced therapy management services to specialty patients via ... Aurora will use the OTM platform ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis Corp., ... independent members to its Board of Directors, enhancing ... of the company, a leading licensed producer of ... Internationally, Bedrocan has 13 years, experience in producing ... seven countries, including Canada. As ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3
... manufacturer of ergonomic laboratory equipment, has partnered with ... Laboratory Centrifuges to North and Latin America. ... and manufacturing of laboratory centrifuges, Awel holds exclusive patented ... with an emphasis on ergonomics. (Photo: ...
... Calif., March 27, 2012 Jacobs Engineering Group Inc. ... of its projects received Facility of the Year Awards ... INTERPHEX and Pharmaceutical Processing magazine, sponsors of the awards ... Program of Projects at the Merck facility in Durham, ...
Cached Medicine Technology:NuAire Introduces Awel Centrifuges to North and Latin America 2Jacobs' Projects Selected "Facility of the Year Award" Winners 2
(Date:8/21/2014)... The International and American Associations for Dental Research (IADR/AADR) ... Prevalence Following Five Decades of Decline." This study, by ... Chapel Hill, USA, follows edentulism (tooth loss) over the ... losing teeth and requiring dentures. It is published in ... Dental Research ( JDR ). , The ...
(Date:8/21/2014)... United Benefit Advisors (UBA), the ... pleased to announce Trinity Benefit Advisors as its ... Trinity Benefit Advisors is a full service firm ... clients. Their consultative approach is comprised of four ... and monitoring. Their dedication to effective results and ...
(Date:8/21/2014)... York (PRWEB) August 21, 2014 According ... Research "Enteral Feeding Devices Market (Enteral Feeding Tubes, Enteral ... - Global Industry Analysis, Size, Share, Growth, Trends and ... was valued at USD 2.0 billion in 2012 and ... 3.1 billion in 2019growing at a CAGR of 6.2% ...
(Date:8/21/2014)... authorities need to ensure that experimental drugs to treat ... randomized controlled trials, according to a new Viewpoint, published ... 2014]. , Leading bioethicists Professor Ezekiel Emanuel, ... Annette Rid, of King,s College London, UK, outline critical ... experimental drugs are to be deployed in the Ebola ...
(Date:8/21/2014)... Albany, NY (PRWEB) August 21, 2014 ... 2020 - Novel Therapeutic Approaches Target High Unmet ... provides in-depth analysis of the Glioblastoma Multiforme (GBM) ... Australia, China, India and Japan. The report provides ... market forecasts until 2020. It also covers disease ...
Breaking Medicine News(10 mins):Health News:Study shows steep decline in tooth loss, increase in socioeconomic disparities 2Health News:Trinity Benefit Advisors is the Latest Firm to Join United Benefit Advisors 2Health News:Trinity Benefit Advisors is the Latest Firm to Join United Benefit Advisors 3Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 2Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 3Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 4Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 5Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 6Health News:Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz 7
... Healthcare Access for All , , WASHINGTON, June ... Foundation (PAF) -- a national non-profit organization that seeks ... care, maintenance of employment and preservation of their financial ... debilitating diseases -- are in Washington, D.C. this week ...
... Inc., a developer of innovative therapies in women,s health, ... Coast Service Options, Inc. ("First Coast"), a large regional ... Puerto Rico and the U.S. Virgin Islands, has removed ... incontinence (SUI) from its noncovered services list and will ...
... /PRNewswire-FirstCall/ - AlphaRx Inc. (OTCBB: ALRX) releases letter to their shareholders: ... take a few minutes to update the current views on AlphaRx. ... last quarter with a small profit. Aside from the fact that ... one front. The events that occurred over the past few weeks, ...
... SignatureForum, a leading online source for consumer reviews ... the highest-rated cosmetic surgeons of the past year. The ... Providers group announced last month, is developed by processing ... United States and Canada. Rated on an overall scale ...
... to Treat Diseases (HTDS.PK) www.htdsmedical.com - announced ... recovering intellectual property (IP) rights that could provide an ... retained a USA based IP consultant to attempt to ... shareholder and its corporate advisors, verily believe was inappropriately ...
... YORK, June 24 Many Americans feel that today,s healthcare ... insurance premiums have made it more difficult to afford health ... resolution expert and physical therapist Mitchell Yass, is whether the ... believes they are not -- and what healthcare segment seems ...
Cached Medicine News:Health News:Patient Advocates From All 50 States Gather in Nation's Capitol to Meet With Lawmakers and Urge Passage of Comprehensive Health Care Reform 2Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 2Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 3Health News:AlphaRx Shareholder Update 2Health News:SignatureForum Reveals Top-Rated Cosmetic Surgeons in US 2Health News:Hard To Treat Diseases (HTDS.PK) To Regain Intellectual Property (IP) Ownership 2Health News:Hard To Treat Diseases (HTDS.PK) To Regain Intellectual Property (IP) Ownership 3Health News:One Man's Mission to Improve Our Healthcare System and Resolve Chronic Pain 2
... camera systems for optimum image quality ... digital camera system records live cells, ... fast exposure times at the lowest ... the visible spectrum assure reliable results ...
... U-III's compact, sleek design and ... sensor, make it the system ... applications including FISH. It is ... institutes and universities and wherever ...
Coolpix 5000 microscope package includes Coolpix 5000 digital camera, MDC-A relay lens, EH52 AC adapter, UR-E6 step-down adapter ring, EU-1 wired remote control unit....
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi...
Medicine Products: